These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19362816)

  • 21. Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report.
    Papi L; Palli D; Masi L; Putignano AL; Congregati C; Zanna I; Marini F; Giusti F; Luzi E; Tonelli F; Genuardi M; Brandi ML; Falchetti A
    Cancer Genet Cytogenet; 2009 Nov; 195(1):75-9. PubMed ID: 19837273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Legal framework relating to human tissues used for research ends].
    Pascal P; Bensiam F; Auxenfans C; Callu MF; Robert O; Damour O; Chapuis F
    Pathol Biol (Paris); 2005 Dec; 53(10):571-5. PubMed ID: 16364808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer genomics based on biobanks.
    Försti A; Hemminki K
    Methods Mol Biol; 2011; 675():375-85. PubMed ID: 20949404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline mutation of microRNA-125a is associated with breast cancer.
    Li W; Duan R; Kooy F; Sherman SL; Zhou W; Jin P
    J Med Genet; 2009 May; 46(5):358-60. PubMed ID: 19411564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human tissue legislation: listening to the professionals.
    Campbell AV; McLean SA; Gutridge K; Harper H
    J Med Ethics; 2008 Feb; 34(2):104-8. PubMed ID: 18234949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptive use and BRCA penetrance: a case-only study.
    Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How early to test for a cancer-causing germline mutation.
    Lynch HT; Lynch JF
    Cancer Genet Cytogenet; 2008 Jan; 180(1):87-8. PubMed ID: 18068543
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part II).
    Lynch HT; Snyder CL; Lynch JF
    Breast J; 2009; 15 Suppl 1():S11-9. PubMed ID: 19775324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted tailored management of the breast cancer patient at risk for harboring a germline mutation-current trends affecting the selection of patients considering surgical prophylaxis for breast cancer.
    Silva E
    Breast J; 2009; 15 Suppl 1():S76-80. PubMed ID: 19775334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Addiction and brief-systemic therapy: working with compulsion].
    Cottencin O; Doutrelugne Y; Goudemand M; Consoli SM
    Encephale; 2009 Jun; 35(3):214-9. PubMed ID: 19540406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medical records and third party personal data processed in the patient's interest].
    Negrini G; La Pietra L
    Ig Sanita Pubbl; 2004; 60(6):485-94. PubMed ID: 17206236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligonucleotide probe array for p53 gene alteration analysis in DNA from formalin-fixed paraffin-embedded breast cancer tissues.
    Lumachi F; Marino F; Varotto S; Basso U
    Ann N Y Acad Sci; 2009 Sep; 1175():89-92. PubMed ID: 19796081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preserving consent-for-consent with feasibility-assessment and recruitment in clinical studies: FARSITE architecture.
    Ainsworth J; Buchan I
    Stud Health Technol Inform; 2009; 147():137-48. PubMed ID: 19593052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory and ethical considerations for linking clinical and administrative databases.
    Dokholyan RS; Muhlbaier LH; Falletta JM; Jacobs JP; Shahian D; Haan CK; Peterson ED
    Am Heart J; 2009 Jun; 157(6):971-82. PubMed ID: 19464406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dramatic response to platinum in a patient with cancer with a germline BRCA2 mutation.
    Moule R; Sohaib A; Eeles R
    Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):444-7. PubMed ID: 19574032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing a family risk assessment clinic for breast cancer.
    Mulsow J; Lee J; Dempsey C; Rothwell J; Geraghty JG
    Breast J; 2009; 15 Suppl 1():S33-8. PubMed ID: 19775328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA2 alteration is important in clear cell carcinoma of the ovary.
    Goodheart MJ; Rose SL; Hattermann-Zogg M; Smith BJ; De Young BR; Buller RE
    Clin Genet; 2009 Aug; 76(2):161-7. PubMed ID: 19656163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.